ArticleFrontiers in medicine2025
Prenatal carrier screening for spinal muscular atrophy among pregnant Thai women.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To investigate the acceptance rate for spinal muscular atrophy (SMA) carrier screening among Thai pregnant women, their attitudes toward the prenatal screening, carrier rate, and the frequencies of Methods: Singleton pregnant women who aged ≥ 18 years, with a gestational age of ≤ 14 weeks at their first visit, were invited to participate the study. All participants completed the questionnaire: Section I-demographic data. Then, they received a pre-test group counseling, followed by an offer of SMA carrier testing at no cost and completion of the questionnaire: Section II-awareness and attitudes toward the screening and Section III-reasons for their choosing "to have" or "not to have" the screening done. Only those having the test done and undergoing post-test counseling were asked to complete the questionnaire: Section IV-attitudes toward the screening process. Results: The preexisting knowledge about SMA was low (30.8%). After pre-test counseling, the majority of participants (94.4%) realized the severity of SMA and its burden to the families, leading to a high acceptance rate for carrier screening at 91.4% (181/198). Most participants (92.4%) agreed to have a fetal diagnosis if they were found to be a couple at risk. The genetic screening revealed a SMA carrier rate of 2.2% (1 in 45), and a high frequency of ≤ 2 copies of Conclusion: The high acceptance rate and positive attitude toward prenatal SMA carrier was demonstrated among Thai pregnant women. Data from the present study highlight urgent needs for endorsement from professional society and public health policy in advancing the SMA carrier screening program in Thailand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.